Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients

被引:455
作者
Kollef, MH
机构
[1] Washington Univ, Sch Med, Div Pulm & Crit Care, Dept Internal Med, St Louis, MO 63110 USA
[2] Barnes Jewish Hosp, Med Crit Care Serv, St Louis, MO 63110 USA
[3] Barnes Jewish Hosp, Resp Care Serv, St Louis, MO 63110 USA
关键词
D O I
10.1086/314079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inadequate antimicrobial treatment, generally defined as microbiological documentation of an infection that is not being effectively treated, is an important factor in the emergence of infections due to antibiotic-resistant bacteria. Factors that contribute to inadequate antimicrobial treatment of hospitalized patients include prior antibiotic exposure, use of broad-spectrum antibiotics, prolonged length of stay, prolonged mechanical ventilation, and presence of invasive devices. Strategies to minimize inadequate treatment include consulting an infectious disease specialist, using antibiotic practice guidelines, and identifying quicker methods of microbiological identification. In addition, clinicians should determine the prevailing pathogens that account for the community-acquired and nosocomial infections identified in their hospitals, Clinicians can improve antimicrobial treatment by using empirical combination antibiotic therapy based on individual patient characteristics and the predominant bacterial flora and their antibiotic susceptibility profiles. This broad-spectrum therapy can then be narrowed when initial culture results are received. Further study evaluating the use of antibiotic practice guidelines and strategies to reduce inadequate treatment is necessary to determine their impact on patient outcomes.
引用
收藏
页码:S131 / S138
页数:8
相关论文
共 97 条
  • [1] Methicillin-resistant Staphylococcus aureus in two child care centers
    Adcock, PM
    Pastor, P
    Medley, F
    Patterson, JE
    Murphy, TV
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) : 577 - 580
  • [2] Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    AlvarezLerma, F
    Pellus, AM
    Sanchez, BA
    Ortiz, EP
    Jorda, R
    Barcenilla, F
    Maravi, E
    Galvan, B
    Palomar, M
    Serra, J
    Bermejo, B
    Mateu, A
    Quintana, E
    Palacios, MS
    Giral, R
    Gonzalez, V
    Lerma, FA
    Mesa, JL
    Melgarejo, JA
    Martinez, J
    Insausti, J
    Olaechea, P
    Chanovas, M
    Gilabert, A
    Junquera, C
    Valles, J
    Palacios, F
    Calvo, R
    Mesalles, E
    Nava, J
    Santos, A
    Armengol, S
    Marzo, D
    [J]. INTENSIVE CARE MEDICINE, 1996, 22 (05) : 387 - 394
  • [3] Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit
    Archibald, L
    Phillips, L
    Monnet, D
    McGowan, JE
    Tenover, F
    Gaynes, R
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 211 - 215
  • [4] The use of antimicrobials in ten Australian and New Zealand intensive care units
    Bellomo, R
    Bersten, AD
    Boots, RJ
    Bristow, PJ
    Dobb, GJ
    Finfer, SR
    McArthur, CJ
    Richard, B
    Skowronski, GA
    [J]. ANAESTHESIA AND INTENSIVE CARE, 1998, 26 (06) : 648 - 653
  • [5] Evaluating treatment protocols to prevent antibiotic resistance
    Bonhoeffer, S
    Lipsitch, M
    Levin, BR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12106 - 12111
  • [6] Nosocomial pneumonia in the ICU - Year 2000 and beyond
    Bowton, DL
    [J]. CHEST, 1999, 115 (03) : 28S - 33S
  • [7] BRYAN CS, 1983, REV INFECT DIS, V5, P629
  • [8] Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia
    Byl, B
    Clevenbergh, P
    Jacobs, F
    Struelens, MJ
    Zech, F
    Kentos, A
    Thys, JP
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 60 - 66
  • [9] Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin
    Caballero-Granado, FJ
    Cisneros, JM
    Luque, R
    Torres-Tortosa, M
    Gamboa, F
    Díez, F
    Villanueva, JL
    Pérez-Cano, R
    Pasquau, J
    Merino, D
    Menchero, A
    Mora, D
    López-Ruz, MA
    Vergara, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) : 520 - 525
  • [10] Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711